Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Hirsch

Showing results (21-30 of 265) with videos related to

Pageof 27
Sort By:
Antiviral Therapy|January 1, 1996
A bend in the road--implications of ACTG 175 and Delta trialsM S Hirsch, P Yeni
Annals of the New York Academy of Sciences|January 1, 1984
Cytomegalovirus-induced immunosuppressionM S Hirsch, D Felsenstein
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 24, 1998
What price progress? Pseudo-Cushing's syndrome associated with antiretroviral therapy in patients with human immunodeficiency virus infectionM S Hirsch, A Klibanski
Proceedings of the Association of American Physicians|April 1, 1995
Combination antiretroviral therapy for the treatment of human immunodeficiency virus type-1 infectionC C Wilson, M S Hirsch
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 1994
Combination therapy for infection due to human immunodeficiency virus type 1A M Caliendo, M S Hirsch
The New England Journal of Medicine|October 20, 1983
Drug therapy. Treatment of herpesvirus infectionsM S Hirsch, R T Schooley
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1971
Role of basophilic leukocytes in cellular immunity to vaccinia virus infectionH F Dvorak, M S Hirsch
The New England Journal of Medicine|October 25, 1973
Cytosine arabinoside versus virus or man?A W Karchmer, M S Hirsch
AIDS Clinical Review|January 1, 1990
New developments in antiretroviral drug therapy for human immunodeficiency virus infectionsV A Johnson, M S Hirsch
Scientific American|April 1, 1987
Antiviral therapyM S Hirsch, J C Kaplan
Pageof 27

Showing results (21-30 of 265) with videos related to

Sort By:
Pageof 27
Antiviral Therapy|January 1, 1996
A bend in the road--implications of ACTG 175 and Delta trialsM S Hirsch, P Yeni
Annals of the New York Academy of Sciences|January 1, 1984
Cytomegalovirus-induced immunosuppressionM S Hirsch, D Felsenstein
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 24, 1998
What price progress? Pseudo-Cushing's syndrome associated with antiretroviral therapy in patients with human immunodeficiency virus infectionM S Hirsch, A Klibanski
Proceedings of the Association of American Physicians|April 1, 1995
Combination antiretroviral therapy for the treatment of human immunodeficiency virus type-1 infectionC C Wilson, M S Hirsch
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 1994
Combination therapy for infection due to human immunodeficiency virus type 1A M Caliendo, M S Hirsch
The New England Journal of Medicine|October 20, 1983
Drug therapy. Treatment of herpesvirus infectionsM S Hirsch, R T Schooley
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1971
Role of basophilic leukocytes in cellular immunity to vaccinia virus infectionH F Dvorak, M S Hirsch
The New England Journal of Medicine|October 25, 1973
Cytosine arabinoside versus virus or man?A W Karchmer, M S Hirsch
AIDS Clinical Review|January 1, 1990
New developments in antiretroviral drug therapy for human immunodeficiency virus infectionsV A Johnson, M S Hirsch
Scientific American|April 1, 1987
Antiviral therapyM S Hirsch, J C Kaplan
Pageof 27